Inhibition of isoproterenol-induced tachycardia by azimilide in the isolated perfused guinea pig heart

Cardiovascular Drugs and Therapy

Volumn 12, Issue 1, 1998, Pages 83-91

  Miller, Kim E ^a,b   Carpenter, John F ^a   Brooks, Robert R ^a  

^a PROCTER AND GAMBLE PHARMACEUTICALS   (United States)

^b PROCTER AND GAMBLE COMPANY   (United States)

Author keywords

Antiarrhythmic agent; Azimilide; Beta blocker; Class III; Guinea pig; Heart; Inhibition; Isoproterenol; Perfusion; Tachycardia

Indexed keywords

ANTIARRHYTHMIC AGENT; AZIMILIDE; BETA ADRENERGIC RECEPTOR; CLOFILIUM; DOFETILIDE; ISOPRENALINE; PROPRANOLOL; SEMATILIDE; SOTALOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; GUINEA PIG; HEART RATE; ISOLATED HEART; MALE; NONHUMAN; PRIORITY JOURNAL; QT INTERVAL; TACHYCARDIA;

ANIMALS; ANTI-ARRHYTHMIA AGENTS; CALCIUM CHANNEL BLOCKERS; ELECTROCARDIOGRAPHY; GUINEA PIGS; HEART; HEART RATE; IMIDAZOLES; IMIDAZOLIDINES; ISOPROTERENOL; MALE; PIPERAZINES; QUATERNARY AMMONIUM COMPOUNDS; RECEPTORS, ADRENERGIC, BETA; SOTALOL; TACHYCARDIA;

EID: 0031897359     PISSN: 09203206     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1007766220822     Document Type: Article

References (26)

1. Black SC, Butterfield JL, Lucchesi BR. Protection against programmed electrical stimulation-induced ventricular tachycardia and sudden cardiac death by NE-10064, a class III antiarrhythmic drug. J Cardiovasc Pharmacol 1993;22: 810-881.
2. Brooks RR, Carpenter JF, Miller KE, Maynard AE. Efficacy of the class III antiarrhythmic agent azimilide in rodent models of ventricular arrhythmia. Proc Soc Exp Biol Med 1996;212:84-93.
3. Drexler AP, Micklas JM, Brooks RR. Suppression of inducible ventricular arrhythmias by intravenous azimilide in dogs with previous myocardial infarction. J Cardiovasc Pharmacol 1996;28:848-855.
4. + current is composed of two currents in guinea pig atrial cells. Am J Physiol 1991;260:H393-H399.
5. + current. Differential sensitivity to block by class III antiarrhythmic agents. J Gen Physiol 1990;96: 195-215.
6. Kiehn J, Villena P, Beyer T, Brachmann J. Differential effects of the new class III agent dofetilide on potassium currents in guinea pig myocytes. J Cardiovasc Pharmacol 1994;24:566-572.
7. +-current by dofetilide. Circ Res 1993;72:75-83.
8. Busch AE, Malloy K, Groh WJ, Varnum MD, Adelman JP, Maylie J. The novel class III antiarrhythmics NE-10064 and NE-10133 inhibit I-sk channels expressed in Xenopus oocytes and I-ks in guinea pig cardiac myocytes. Biochem Biophys Res Commun 1994;202:265-270.
9. + currents in cardiac cells (abstr). Biophys J 1994;66:A326.
10. Fermini B, Jurkiewicz NK, Jow B, Guinosso PJ, Baskin EP, Lynch JJ, Salata JJ. Use-dependent effects of the class III antiarrhythmic agent NE-10064 (azimilide) on cardiac repolarization: Block of delayed rectifier potassium and L-type calcium currents. J Cardiovasc Pharmacol 1995;26:259-271.
11. Yao T, Tseng GN. Azimilide (NE-10064) can prolong or shorten the action potential duration in canine ventricular myocytes: Dependence on blockade of K, Ca, and Na channels. J Cardiovasc Electrophysiol 1997;8:184-189.
12. Pong SF, Kinney CM, Moorehead TJ. Binding profile of NE-10064, a novel class III antiarrhythmic agent, to rat brain receptors (abstr.) FASEB J 1993;7:A474.
13. Sanguinetti M, Jurkiewicz NK, Scott AL, Siegl PKS. Isoproterenol antagonizes the prolongation of refractory period by the class III antiarrhythmic agent E-4031 in guinea pig myocytes. Mechanism of action. Circ Res 1991;68:77-84.
14. Herzer T, Wagner CA, Waldegger S, Lang F, Busch AE. Effect of channel modulation and pH on IsK inhibition by the novel class III antiarrhythmic azimilide (NE-10064). Eur J Pharmacol 1995;291:205-208.
15. Groh WJ, Maylie JG. Efficacy of NE-10064 in maintaining repolarizing current block after d,l-sotalol and isoproterenol (abstr.) PACE 1994;17:755-760.
16. Gomoll AW, Bartek MJ. Comparative beta-blocking activities and electrophysiologic actions of racemic sotalol and its optical isomers in anesthetized dogs. Eur J Pharmacol 1986;1312:123-135.
17. Miller KE, Carpenter JF, Brooks RR. Beta adrenergic receptor response of guinea pig heart in the presence of class III antiarrhythmics (abstr.) FASEB J 1991;5:A1216.
18. Miller KE, Carpenter JF, Brooks RR. β-adrenergic effects of the class III antiarrhythmic agent NE-10064 in the isolated perfused guinea pig heart, (abstr.) FASEB J 1993;7:A108.
19. Burger W, Chemnitius JM, Bing RJ. A new method for visualization of subepicardial coronary arteries in small isolated mammalian hearts. Proc Soc Exp Biol Med 1985;178: 309-312.
20. Sosunov EA, Anyukhovsky EP, Rosen MR. Chronic in vivo and in vitro effects of amiodarone on guinea pig hearts. J Pharmacol Exp Ther 1996;278:906-912.
21. Design of β-blocking drugs. In: Barrett AM, Ariens EJ, eds. Drug Design, Vol. III. New York: Academic Press, 1972: 205-228.
22. Adrenergic receptor antagonists. In: Hoffman BB, Lefkowitz RJ, Gilman AG, Rall TW, Nies AS, Taylor P, eds. The Pharmacologic Basis of Therapeutics, 8th ed. New York: Pergammon Press, 1990: 221-243.
23. Levesque L, Clark CD, Zakharov SI, Rosenshtrankh LV, Hume JR. Anion and cation modulation of the guinea-pig ventricular action potential during beta-adrenoceptor stimulation. Pflugers Arch 1993;424:54-62.
24. Brooks RR, Butterfield JL. The class III antiarrhythmic NE-10064 increased QTc interval with minor hemodynamic effects in anesthetized dogs (abstr.), Can J Physiol Pharmacol 1994;72(Suppl. 1):79.
25. Drexler AP, Micklas JM, Brooks RR. Suppression of inducible ventricular arrhythmias by intravenous azimilide in dogs with previous myocardial infarction. J Cardiovasc Pharmacol 1996;28:848-855.
26. Drexler AP, McCulloch JD, Jorgensen RL, Johnson NC, Brooks RR. Simple relationship between intravenous dose, plasma concentration and class III effects of azimilide in conscious dogs. (abstr.), FASEB J 1997;11:A493.